1. Home
  2. CLFD vs VNDA Comparison

CLFD vs VNDA Comparison

Compare CLFD & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clearfield Inc.

CLFD

Clearfield Inc.

HOLD

Current Price

$30.54

Market Cap

402.8M

Sector

Utilities

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$5.18

Market Cap

361.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLFD
VNDA
Founded
1979
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
402.8M
361.4M
IPO Year
1995
2005

Fundamental Metrics

Financial Performance
Metric
CLFD
VNDA
Price
$30.54
$5.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$43.50
$14.90
AVG Volume (30 Days)
170.0K
844.1K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
31.76
N/A
EPS
N/A
N/A
Revenue
$85,034,000.00
$216,105,000.00
Revenue This Year
$11.64
$21.35
Revenue Next Year
$22.30
$37.40
P/E Ratio
N/A
N/A
Revenue Growth
9.51
8.72
52 Week Low
$23.76
$4.14
52 Week High
$52.73
$9.91

Technical Indicators

Market Signals
Indicator
CLFD
VNDA
Relative Strength Index (RSI) 35.18 30.33
Support Level $28.61 $5.11
Resistance Level $30.99 $5.58
Average True Range (ATR) 1.38 0.24
MACD -0.12 -0.08
Stochastic Oscillator 16.35 0.00

Price Performance

Historical Comparison
CLFD
VNDA

About CLFD Clearfield Inc.

Clearfield Inc designs, manufactures, and distributes fiber protection, fiber management, and fiber delivery solutions to enable rapid and cost-effective fiber-fed deployment throughout the broadband service provider space prominently across North America. Its 'fiber to anywhere' platform serves the requirements of Community Broadband customers, Multiple System Operators, Large Regional Service Providers, National Carriers, and International customers (including Europe, Canada, Mexico, and Caribbean Markets). Its product offerings include Accessories, Cassettes, Cable & Drop Assemblies, Frames & Panels, Microducts, Optical Components, etc. The company derives the majority of its revenue from the United States.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: